Quick Answer
INTEGRATED BIOPHARMA INC reported Operating Income of $2.02 million for fiscal year 2025.
INTEGRATED BIOPHARMA INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $2.02M | +704.8% |
| 2024 | $251.0K | +109.2% |
| 2023 | $120.0K | -95.6% |
| 2022 | $2.75M | -52.5% |
| 2021 | $5.78M | +77.5% |
| 2020 | $3.26M | +20.5% |
| 2019 | $2.70M | +59.6% |
| 2018 | $1.69M | -46.8% |
| 2017 | $3.19M | +50.8% |
| 2016 | $2.11M | +126.6% |
| 2015 | $933.0K | -31.0% |
| 2014 | $1.35M | +21.1% |
| 2013 | $1.12M | +320.6% |
| 2012 | -$506.0K | -39.8% |
| 2011 | -$362.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$914.0K | -552.5% | -660.7% |
| September 30, 2025 | $163.0K | -66.7% | -77.9% |
| March 31, 2025 | $739.0K | +108.2% | +265.8% |
| December 31, 2024 | $202.0K | +144.7% | -58.8% |
| September 30, 2024 | $490.0K | +1007.4% | +38.0% |
| March 31, 2024 | $355.0K | +706.8% | +178.5% |
| December 31, 2023 | -$452.0K | -1269.7% | -737.0% |
| September 30, 2023 | -$54.0K | -280.0% | -222.7% |
- INTEGRATED BIOPHARMA INC showed an increase of +704.8% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, INTEGRATED BIOPHARMA INC’s operating income has grown by 658.0% (from -$362.0 thousand to $2.02 million).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: